Stockscreener 앱 받기
24.40
2.05%
-0.51
시간 외 거래:
24.30
-0.10
-0.41%
Elanco Animal Health Inc 주식(ELAN)의 최신 뉴스
Investment Report: Is Elanco Animal Health Incorporated attractive for institutional investorsWeekly Gains Report & Daily Momentum Trading Reports - baoquankhu1.vn
Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight with $30 Price Target - Intellectia AI
Elanco (ELAN) Upgraded by Piper Sandler Amid Corporate Gains - GuruFocus
Elanco Animal Health stock hits 52-week high at 25.0 USD - Investing.com Canada
Elanco upgraded, Zoetis downgraded at Piper Sandler (ELAN:NYSE) - Seeking Alpha
Piper Sandler upgrades Elanco as co gains traction with veterinary groups - Investing.com Canada
Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement - Finviz
Breaking Down Elanco Animal Health: 5 Analysts Share Their Views - Benzinga
Alphabet To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Thursday - Benzinga
Elanco (ELAN) Upgraded by Analyst with Increased Price Target - GuruFocus
Piper Sandler Upgrades Elanco Animal Health (ELAN) and Raises Pr - GuruFocus
This Elanco Animal Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday - Benzinga
Feline Vaccines Market Overview and Leading Players: Merck & Co, - openPR.com
Elanco Animal Health Incorporated $ELAN Shares Acquired by Amalgamated Bank - MarketBeat
Pet Pharmaceuticals Market Is Booming Worldwide 2026-2033 | Zoetis • Merck Animal Health • Elanco Animal Health - openPR.com
Animal Parasiticides Market with Insights from Boehringer - openPR.com
Animal Health Market Overview and Leading Players: Bayer, Ceva - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year High on Analyst Upgrade - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Elanco Animal Health (ELAN) Stock Analysis: Navigating Growth Potential Amidst Market Dynamics - DirectorsTalk Interviews
Poultry Antibiotic Market Is Booming Worldwide 2026-2033 - openPR.com
The Glucosamine Supplements for Dogs Market, Global Forecast 2026-2032 | Innovation Drives Canine Glucosamine Supplement Market with New Chewable and Liquid Formats - GlobeNewswire Inc.
Veterinary Vaccines Market to Reach USD 236 Million by 2031 | CAGR - openPR.com
Anticoccidial Drugs Market to Reach USD 2.52 Billion by 2033 | - openPR.com
Elanco Animal Health (NYSE:ELAN) Upgraded by Wall Street Zen to Strong-Buy Rating - MarketBeat
State of Alaska Department of Revenue Takes Position in Elanco Animal Health Incorporated $ELAN - MarketBeat
New York State Teachers Retirement System Invests $5.50 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
ASR Vermogensbeheer N.V. Trims Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Institution Moves: What is the next catalyst for Elanco Animal Health IncorporatedJuly 2025 Sentiment & Capital Efficient Trading Techniques - baoquankhu1.vn
Nisa Investment Advisors LLC Lowers Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
Investor Mood: Can Elanco Animal Health Incorporated reach all time highs this yearTrade Exit Report & AI Optimized Trade Strategies - baoquankhu1.vn
Risk Hedge: Can Elanco Animal Health Incorporated ride the EV wave2025 Biggest Moves & Reliable Entry Point Alerts - baoquankhu1.vn
Elanco Animal Health stock hits 52-week high at 24.51 USD - Investing.com Canada
Oregon Public Employees Retirement Fund Invests $2.01 Million in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Purchased by SG Americas Securities LLC - MarketBeat
Veterinary Oncology Market Is Going to BoomGrowth - openPR.com
Merger Talk: Why Elanco Animal Health Incorporated stock could outperform in 2025July 2025 Action & High Accuracy Buy Signal Tips - moha.gov.vn
Elanco CEO: Gaining Market Share Via 'Major' Innovations - marketscreener.com
Elanco Animal Health (NYSE:ELAN) Sets New 52-Week HighHere's Why - MarketBeat
Trend Recap: What is the PEG ratio of Elanco Animal Health IncorporatedBull Run & Long-Term Safe Investment Ideas - baoquankhu1.vn
Elanco Animal Health Inc Presents at J.P. Morgan Healthcare Conference - TradingView
Elanco Animal Health (NYSE:ELAN) Downgraded by Wall Street Zen to "Buy" - MarketBeat
Louisiana State Employees Retirement System Makes New Investment in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health: Innovation-Led Growth Model Plus Credible Deleveraging Path (ELAN) - Seeking Alpha
Will Elanco Animal Health Incorporated stock benefit from automation2025 Performance Recap & Reliable Breakout Forecasts - ulpravda.ru
Will Elanco Animal Health Incorporated (5EA) stock outperform value peers2025 Major Catalysts & Smart Investment Allocation Tips - ulpravda.ru
S P Trends: Will Elanco Animal Health Incorporated stock outperform energy sector in 2025Market Performance Report & Technical Analysis for Trade Confirmation - ulpravda.ru
Will Elanco Animal Health Incorporated stock outperform energy sector in 2025Market Movement Recap & Daily Profit Maximizing Tips - ulpravda.ru
Assessing Elanco Animal Health (ELAN) Valuation After Befrena Approval And Turnaround Progress - Yahoo Finance
Veterinary Pain Management Drugs Market to hit US$ 3.00 Billion - openPR.com
Elanco Animal Health (NYSE:ELAN) Hits New 1-Year HighHere's What Happened - MarketBeat
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), IQVIA Holdings (IQV) and Ascendis Pharma (ASND) - The Globe and Mail
Elanco Animal Health stock hits 52-week high at 23.71 USD - Investing.com Canada
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Finviz
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
Elanco Animal Health (ELAN) Valuation Check After Recent Share Price Pullback - simplywall.st
On-Farm Veterinary Diagnostic Solutions Market Booming with - openPR.com
Dogs Vaccines Market Strong Growth: New Report Highlights - openPR.com
Elanco Animal Health Inc (ELAT) Fundamental Analysis - Meyka
Breaking News - Today's Veterinary Business
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Elanco Receives USDA Approval for Befrena (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis - Finviz
Elanco (ELAN) Gains USDA Approval for Befrena Injections - GuruFocus
Elanco (ELAN) Gains USDA Approval for New Canine Dermatology Tre - GuruFocus
Elanco gains approval of Befrena for canine dermatitis - Seeking Alpha
0.22%
2.08%
자본화:
|
볼륨(24시간):